Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis

There is an urgent need for new immunodominant antigens to improve the diagnosis of tuberculosis (TB) and the efficacy of the TB vaccine to control the disease worldwide. In this study, we evaluated the diagnostic potential of a novel Mycobacterium tuberculosis (MTB)-specific antigen, Rv2351c, from...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Emerg Microbes Infect
Päätekijät: Wang, Xuezhi, Chen, Shuangshuang, Xu, Yongjuan, Zheng, Huajun, Xiao, Tongyang, Li, Yuqing, Chen, Xing, Huang, Mingxiang, Zhang, Haifeng, Fang, Xijing, Jiang, Yi, Li, Machao, Liu, Haican, Wan, Kanglin
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group 2017
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5520311/
https://ncbi.nlm.nih.gov/pubmed/28588287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emi.2017.34
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia